Longitudinal analysis of SARS-CoV-2 antibodies in 8000 U.S. first-time convalescent plasma donations.
Longitudinal analysis of SARS-CoV-2 antibodies in 8000 U.S. first-time convalescent plasma donations.
复制标题
DOI:
10.1111/trf.16291
复制
发表时间:
2021-04
期刊:
影响因子:
2.9
通讯作者:
Kreil TR
中科院分区:
文献类型:
--
作者:
Karbiener M;Farcet MR;Ilk R;Schreiner J;Lenart J;Powers N;Stewart JM;Tallman H;Kreil TR
Coronavirus disease 2019 (COVID‐19) convalescent individuals carry antibodies against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) that, through a plasma donation, can be used as a potential therapeutic either in direct transfusion or for the manufacture of hyperimmune globulin (HIG). The success of such interventions depends on the antibody potency in such plasma donations, but little information on the collection of potent units is currently available. A total of 8749 plasma units, collected from April until September 2020 from first‐time U.S. COVID‐19 convalescent plasma donors, were characterized for SARS‐CoV‐2 immunoglobulin G (IgG) antibodies by Abbott chemiluminescent microparticle immunoassay (CMIA). The period between COVID‐19 onset until donation and donor age, ethnicity, sex, and COVID‐19 severity were evaluated against the obtained signal (index S/C). A marked decrease in mean index S/C was seen over the plasma collection period surveyed, which was significantly correlated to decreases in mean plasma donor age (p < .0001; R2 = .726) and percentage of donations obtained from COVID‐19 convalescent patients who had been hospitalized (p = .001; R2 = .4426). The highest titer plasma units were obtained soon after convalescence from COVID‐19 patients who required hospitalization, from advanced age donors, and from Black/African/Hispanic American versus White/Caucasian ethnicities, whereas there was no effect of donor sex on the values obtained with the Abbott CMIA. Since the onset of the pandemic, the average SARS‐CoV‐2 IgG values of first‐time U.S. COVID‐19 convalescent plasma donations have significantly dropped, mainly due to donations from progressively younger aged donors who tend to experience less severe COVID‐19.
登录
查看更多内容
DOI:
10.1007/s10096-004-1271-9
发表时间:
2005-01
期刊:
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
影响因子:
--
作者:
Cheng Y;Wong R;Soo YO;Wong WS;Lee CK;Ng MH;Chan P;Wong KC;Leung CB;Cheng G
通讯作者:
Cheng G
影响因子:
24.8
作者:
Isho B;Abe KT;Zuo M;Jamal AJ;Rathod B;Wang JH;Li Z;Chao G;Rojas OL;Bang YM;Pu A;Christie-Holmes N;Gervais C;Ceccarelli D;Samavarchi-Tehrani P;Guvenc F;Budylowski P;Li A;Paterson A;Yue FY;Marin LM;Caldwell L;Wrana JL;Colwill K;Sicheri F;Mubareka S;Gray-Owen SD;Drews SJ;Siqueira WL;Barrios-Rodiles M;Ostrowski M;Rini JM;Durocher Y;McGeer AJ;Gommerman JL;Gingras AC
通讯作者:
Gingras AC
影响因子:
158.5
作者:
Gudbjartsson, Daniel F.;Norddahl, Gudmundur L.;Stefansson, Kari
通讯作者:
Stefansson, Kari
影响因子:
3.3
作者:
Crawford, Katherine M.;Choi, Karmel;Davis, Kathryn A.;Zhu, Yiwen;Soare, Thomas W.;Smith, Andrew D. A. C.;Germine, Laura;Dunn, Erin C.
通讯作者:
Dunn, Erin C.
影响因子:
39.3
作者:
Chen, Xiangyu;Pan, Zhiwei;Ye, Lilin
通讯作者:
Ye, Lilin